VEA
LGND icon

Virtus ETF Advisers’s Ligand Pharmaceuticals LGND Stock Holding History

Quarter Market Value Status Shares Shares
Change %
Trade Value Portfolio Weight Portfolio Position
2025
Q1
Sell
-3,080
Closed -$330K 493
2024
Q4
$330K Sell
3,080
-969
-24% -$104K 0.13% 230
2024
Q3
$405K Hold
4,049
0.19% 201
2024
Q2
$341K Sell
4,049
-1,579
-28% -$133K 0.17% 203
2024
Q1
$411K Buy
5,628
+810
+17% +$59.2K 0.22% 192
2023
Q4
$344K Buy
4,818
+914
+23% +$65.3K 0.22% 192
2023
Q3
$234K Sell
3,904
-501
-11% -$30K 0.14% 230
2023
Q2
$318K Sell
4,405
-399
-8% -$28.8K 0.19% 187
2023
Q1
$353K Buy
4,804
+83
+2% +$6.11K 0.19% 165
2022
Q4
$315K Buy
4,721
+1,572
+50% +$105K 0.16% 244
2022
Q3
$271K Buy
3,149
+46
+1% +$3.96K 0.11% 285
2022
Q2
$277K Buy
3,103
+505
+19% +$45.1K 0.1% 273
2022
Q1
$292K Hold
2,598
0.13% 178
2021
Q4
$401K Sell
2,598
-1,116
-30% -$172K 0.15% 147
2021
Q3
$517K Sell
3,714
-343
-8% -$47.7K 0.23% 134
2021
Q2
$532K Sell
4,057
-2,090
-34% -$274K 0.22% 130
2021
Q1
$937K Buy
6,147
+168
+3% +$25.6K 0.4% 95
2020
Q4
$595K Buy
5,979
+625
+12% +$62.2K 0.25% 117
2020
Q3
$510K Buy
5,354
+451
+9% +$43K 0.27% 133
2020
Q2
$548K Sell
4,903
-644
-12% -$72K 0.26% 136
2020
Q1
$403K Sell
5,547
-468
-8% -$34K 0.17% 197
2019
Q4
$627K Sell
6,015
-440
-7% -$45.9K 0.1% 179
2019
Q3
$643K Sell
6,455
-1,081
-14% -$108K 0.13% 169
2019
Q2
$860K Buy
7,536
+2,033
+37% +$232K 0.18% 165
2019
Q1
$692K Buy
5,503
+1,181
+27% +$149K 1.47% 20
2018
Q4
$586K Buy
4,322
+247
+6% +$33.5K 0.1% 50
2018
Q3
$1.12M Buy
4,075
+275
+7% +$75.5K 0.12% 42
2018
Q2
$787K Sell
3,800
-2,971
-44% -$615K 0.7% 37
2018
Q1
$1.12M Sell
6,771
-390
-5% -$64.4K 0.97% 25
2017
Q4
$981K Sell
7,161
-1,786
-20% -$245K 1.23% 24
2017
Q3
$1.22M Hold
8,947
0.16% 51
2017
Q2
$1.09M Sell
8,947
-695
-7% -$84.4K 0.16% 54
2017
Q1
$1.02M Buy
9,642
+928
+11% +$98.3K 0.18% 66
2016
Q4
$885K Buy
8,714
+3,332
+62% +$338K 0.26% 73
2016
Q3
$549K Buy
5,382
+677
+14% +$69.1K 0.27% 67
2016
Q2
$561K Sell
4,705
-838
-15% -$99.9K 0.42% 34
2016
Q1
$594K Buy
+5,543
New +$594K 0.82% 25